LEIOMYOSARCOMA

Clinical trials for LEIOMYOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new LEIOMYOSARCOMA trials appear

Sign up with your email to follow new studies for LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 19 Not yet recruiting 3 Not yet finished but already full! 11 Completed 6 Terminated 1

Experimental drug tested for rare cancer, trial stopped early

Disease control Terminated

This study tested a drug called XmAb23104 in people with advanced sarcoma, a rare cancer. The goal was to see if the drug could shrink tumors and if it was safe. Only 6 people took part before the study was ended early.

Matched conditions: LEIOMYOSARCOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC

LEIOMYOSARCOMA

Get alerted when new LEIOMYOSARCOMA trials appear

Experimental drug tested for rare cancer, trial stopped early